American Journal of Otolaryngology - Head and Neck Medicine and Surgery
Volume 30, Issue 2 , Pages 89-94 , March 2009

Immunoexpression of cyclooxygenase-2 and p53 in oral squamous cell carcinoma

Received 20 January 2008

References 

  1. Atula T, Hedström J, Ristimäki A, et al. Cyclooxyigenase-2 expression in squamous cell carcinoma of the oral cavity and pharynx: association to p53 and clinical outcome. Oncol Rep. 2006;16(3):485–490
  2. Yu HP, Xu SQ, Liu L, et al. Cyclooxygenase-2 expression in squamous dysplasia and squamous cell carcinoma of the esophagus. Cancer Lett. 2003;198(2):193–201
  3. Chan G, Boyle JO, Yang EK, et al. Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. Cancer Res. 1999;59(5):991–994
  4. Pannone G, Bufo P, Serpico K, et al. Cyclooxygenase-2 expression in oral squamous cell carcinoma. Int J Immunopathol Pharmacol. 2004;17(3):273–282
  5. Minter HA, Eveson JW, Huntley S, et al. The cyclooxygenase-2 selective inhibitor NS398 inhibits proliferation of oral carcinoma cell lines by mechanisms dependent and independent of reduced prostaglandin E2 synthesis. Clin Cancer Res. 2003;9(5):1885–1897
  6. Swamy MV, Herzog CR, Rao CV. Inhibition of COX-2 in colon cancer cell lines by celecoxib increases nuclear localization of active p53. Cancer Res. 2003;63(17):5239–5242
  7. Gottlieb TM, Oren M. P53 in growth control and neoplasia. Biochim Biophys Acta. 1996;1287(2-3):77–102
  8. Kurokawa H, Zhang M, Matsumoto S, et al. The relationship of the histological grade at the deep invasive front and the expression of Ki-67 antigen and p53 protein in oral squamous cell carcinoma. J Oral Pathol Med. 2005;34(10):602–607
  9. Subbaramaiah K, Altorki N, Chung WJ, et al. Inhibition of cyclooxygenase-2 gene expression by p53. J Biol Chem. 1999;274(16):10911–10915
  10. Choi EM, Heo JI, Oh JY, et al. COX-2 regulates p53 activity and inhibits DNA damage-induced apoptosis. Biochem Biophys Res Comm. 2005;328(4):1107–1112
  11. Shibata M, Kodani I, Osaki M, et al. Cyclo-oxygenase-1 and -2 expression in human normal mucosa, dysplasias and squamous cell carcinoma and their pathological significance. Oral Oncol. 2005;41(3):304–312
  12. Bryne M. Is the invasive front of an oral carcinoma the most important area for prognostication?. Oral Dis. 1998;4(2):70–77
  13. Miranda JL. Expressão de proteínas da matriz extracelular em carcinoma epidermóide de lábio inferior e língua. Doctoral Thesis, Universidade Federal do Rio Grande do Norte, 2002.
  14. Itoh S, Matsui K, Furuta I, et al. Immunohistochemical study on overexpression of cyclooxygenase-2 in squamous cell carcinoma of the oral cavity: its importance as a prognostic predictor. Oral Oncol. 2003;39(8):829–835
  15. Renkonen J, Wolff H, Paavonen T. Expression of cyclooxygenase-2 in human tongue carcinoma and its precursor lesions. Virchows Arch. 2002;440(6):594–597
  16. Terakado N, Shintani S, Yano J, et al. Overexpression of cyclooxygenase-2 is associated with radioresistance in oral squamous cell carcinoma. Oral Oncol. 2004;40(4):383–389
  17. Mishima K, Inoue K, Hayashi Y. Overexpression of extracellular-signal regulated kinases on oral squamous cell carcinoma. Oral Oncol. 2002;38(5):468–474
  18. Liu XH, Kirschenbaum A, Yu K, et al. Cycloxygenase-2 suppresses hypoxia-induced apoptosis via a combination of direct and indirect inhibition of p53 activity in a human prostate cancer cell line. J Biol Chem. 2005;280(5):3817–3823
  19. Zimmermann KC, Sarbia M, Weber AA, et al. Cyclooxygenase-2 expression in human esophageal carcinoma. Cancer Res. 1999;59(1):198–204
  20. Pannone G, Sanquedolce F, De Maria S, et al. Cyclooxygenase isozymes in oral squamous cell carcinoma: a real-time RT-PCR study with clinic pathological correlations. Int J Immunopathol Pharmacol. 2007;20(2):317–324
  21. Piffko J, Bonkfolvi A, Ofner D, et al. Expression of p53 protein in oral squamous cell carcinomas and adjacent non-tumorous mucosa of the floor of the mouth: an archival immunohistochemical study using wet autoclave pretreatment for antigen retrieval. J Oral Pathol Med. 1995;24(8):337–342
  22. Gallo O, Schiavone N, Papucci L, et al. Correlation between nitric oxide and cyclooxygenase-2 pathways in head and neck squamous cell carcinomas. Biochem Biophys Res Comm. 2002;299(4):517–524
  23. Corcoran CA, He K, Huang Y, et al. Cyclooxygenase interacts with p53 and interferes with p53-dependent transcription and apoptosis. Oncogene. 2005;24(9):1634–1640
  24. Lee DW, Park SW, Park SW, et al. Effects of p53 or p27 on cycloxygenase-2 gene expression in head and neck squamous cell carcinoma cell lines. Head Neck. 2004;26(8):706–715

PII: S0196-0709(08)00041-0

doi: 10.1016/j.amjoto.2008.02.012

American Journal of Otolaryngology - Head and Neck Medicine and Surgery
Volume 30, Issue 2 , Pages 89-94 , March 2009

Article Tools

* Image Usage & Resolution